2 years ago
BKNG
AnalystsEdward WooEdward Woo's Stock Forecasts
AnalystsEdward Woo
Analyst Ranking
Bottom 1%
#5215 out of 5232 analysts
Average Return
-12.58%
Win Rate
30%74 out of 244
Risk vs Reward
Poor
Good
Edward Woo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aim Immunotech IncAIM | +595.40% | $0.35 | $2.42 | 2024-09-02 - 2025-09-02 | Buy |
Quantum Computing IncQUBT | +593.18% | $0.88 | $6.10 | 2023-11-23 - 2024-11-22 | Buy |
Aim Immunotech IncAIM | +583.49% | $0.22 | $1.49 | 2024-12-09 - 2025-12-09 | Buy |
Quantum Computing IncQUBT | +318.80% | $2.66 | $11.14 | 2024-11-12 - 2025-11-12 | Buy |
Duos Technologies Group IncDUOT | +234.24% | $2.57 | $8.59 | 2024-06-06 - 2025-06-06 | Buy |
Edward Woo Analyst Color
Get additional color on Edward Woo's coverage of popular stocks
Edward Woo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gri Bio IncGRI | 6 | Buy | $40.00 | +1,646.72% | Maintains | 21 days ago |
Genasys IncGNSS | 6 | Buy | $5.50 | +202.20% | Maintains | 21 days ago |
Outlook Therapeutics IncOTLK | 7 | Buy | $6.00 | +2,812.62% | Maintains | 21 days ago |
Nexttrip IncNTRP | 1 | Buy | $7.00 | +115.38% | Initiates Coverage On | a month ago |
Igc Pharma IncIGC | 8 | Buy | $5.00 | +1,801.14% | Maintains | a month ago |
Renovorx IncRNXT | 8 | Buy | $13.00 | +1,187.13% | Maintains | a month ago |
Synergy Chc CorpSNYR | 1 | Buy | $5.00 | +287.60% | Initiates Coverage On | 2 months ago |
Nrx Pharmaceuticals IncNRXP | 7 | Buy | $48.00 | +2,153.52% | Maintains | 3 months ago |
Maison Solutions IncMSS | 3 | Buy | $4.50 | +3,003.45% | Maintains | 3 months ago |
Duos Technologies Group IncDUOT | 8 | Buy | $14.00 | +104.08% | Maintains | 3 months ago |
Alzamend Neuro IncALZN | 7 | Buy | $28.00 | +2,541.51% | Maintains | 3 months ago |
Quantum Computing IncQUBT | 6 | Buy | $25.00 | +264.96% | Maintains | 3 months ago |
Surgepays IncSURG | 9 | Buy | $9.75 | +1,198.27% | Maintains | 3 months ago |
Society Pass IncorporatedSOPA | 7 | Buy | $22.50 | +5,108.33% | Maintains | 3 months ago |
Knightscope IncKSCP | 5 | Buy | $25.00 | +499.52% | Maintains | 4 months ago |
Banzai International IncBNZI | 7 | Buy | $23.00 | +2,318.51% | Maintains | 4 months ago |
Aytu Biopharma IncAYTU | 3 | Buy | $13.00 | +376.19% | Maintains | 4 months ago |
Lucid Diagnostics IncLUCD | 8 | Buy | $8.25 | +617.39% | Maintains | 4 months ago |
Pavmed IncPAVM | 8 | Buy | $510.00 | +4,924.63% | Maintains | 4 months ago |
Allarity Therapeutics IncALLR | 3 | Buy | $9.50 | +771.56% | Maintains | 4 months ago |
Atossa Therapeutics IncATOS | 7 | Buy | $40.00 | +660.46% | Maintains | 4 months ago |
Aim Immunotech IncAIM | 4 | Buy | $22.00 | +3,660.68% | Maintains | 4 months ago |
Sintx Technologies IncSINT | 4 | Buy | $16.00 | +539.23% | Maintains | 4 months ago |
Intrusion IncINTZ | 6 | Buy | $12.50 | +1,422.53% | Maintains | 4 months ago |
Cingulate IncCING | 4 | Buy | $58.00 | +833.98% | Maintains | 4 months ago |
Endra Life Sciences IncNDRA | 5 | Buy | $30.00 | +545.16% | Maintains | 4 months ago |
Plus Therapeutics IncPSTV | 6 | Buy | $19.00 | +11,556.44% | Maintains | 4 months ago |
Myomo IncMYO | 6 | Buy | $10.00 | +1,379.29% | Maintains | 4 months ago |
Aemetis IncAMTX | 5 | Buy | $20.00 | +526.96% | Maintains | 4 months ago |
TravelzooTZOO | 6 | Buy | $23.00 | +288.51% | Maintains | 4 months ago |
Phunware IncPHUN | 6 | Buy | $12.50 | +606.21% | Maintains | 10 months ago |
Streamex CorpSTEX | 4 | Buy | $10.00 | +784.96% | Maintains | 10 months ago |
Ton Strategy CoTONX | 4 | Buy | $62.00 | +2,410.12% | Maintains | 10 months ago |
Envoy Medical IncCOCH | 5 | Buy | $9.50 | +1,328.57% | Maintains | 10 months ago |
Pro Dex IncPDEX | 4 | Buy | $56.00 | +14.01% | Maintains | 10 months ago |
Groupon IncGRPN | 8 | Buy | $19.00 | N/A | Maintains | a year ago |
Daxor CorpDXR | 3 | Buy | $25.00 | N/A | Maintains | a year ago |
Electronic Arts IncEA | 2 | Buy | $160.00 | N/A | Maintains | a year ago |
Take Two Interactive Software IncTTWO | 11 | Buy | $270.00 | N/A | Maintains | a year ago |
Datavault Ai IncDVLT | 3 | Buy | $11.00 | N/A | Maintains | a year ago |
Biolase IncBIOL | 2 | Buy | $2.00 | N/A | Maintains | 2 years ago |
Mira Pharmaceuticals IncMIRA | 1 | Buy | $11.00 | N/A | Initiates Coverage On | 2 years ago |
Jakks Pacific IncJAKK | 1 | Buy | $38.00 | N/A | Maintains | 2 years ago |
Booking Holdings IncBKNG | 2 | Buy | $3,900.00 | N/A | Maintains | 2 years ago |
Expedia Group IncEXPE | 1 | Buy | $168.00 | N/A | Maintains | 2 years ago |
Tripadvisor IncTRIP | 1 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Algorhythm Holdings IncRIME | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Heartsciences IncHSCS | 1 | Buy | $330.00 | N/A | Initiates Coverage On | 3 years ago |
Vivos Therapeutics IncVVOS | 1 | Buy | $62.50 | N/A | Initiates Coverage On | 3 years ago |
Autoweb IncAUTO | 1 | Hold | $0.39 | N/A | Downgrades | 4 years ago |
Guardion Health Sciences IncGHSI | 1 | Buy | $37.50 | N/A | Initiates Coverage On | 4 years ago |
Realloys IncALOY | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Novabay Pharmaceuticals IncNBY | 3 | Buy | $24,500.00 | N/A | Maintains | 4 years ago |
Activision Blizzard IncATVI | 3 | Buy | $95.00 | N/A | Maintains | 4 years ago |
Gamestop CorpGME | 8 | Sell | $5.75 | N/A | Maintains | 4 years ago |
Blue Nile IncNILE1 | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 4 years ago |
Imac Holdings IncBACK | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.